Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs IPCA LABS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA IPCA LABS ABBOTT INDIA/
IPCA LABS
 
P/E (TTM) x 49.5 51.8 95.5% View Chart
P/BV x 18.0 5.4 334.4% View Chart
Dividend Yield % 1.2 0.3 377.9%  

Financials

 ABBOTT INDIA   IPCA LABS
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-23
IPCA LABS
Mar-23
ABBOTT INDIA/
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs22,4821,062 2,117.2%   
Low Rs16,156768 2,103.6%   
Sales per share (Unadj.) Rs2,517.0243.0 1,035.9%  
Earnings per share (Unadj.) Rs446.819.4 2,304.2%  
Cash flow per share (Unadj.) Rs479.729.7 1,615.2%  
Dividends per share (Unadj.) Rs325.004.00 8,125.0%  
Avg Dividend yield %1.70.4 384.8%  
Book value per share (Unadj.) Rs1,480.5230.3 642.9%  
Shares outstanding (eoy) m21.25253.70 8.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.73.8 203.8%   
Avg P/E ratio x43.247.2 91.6%  
P/CF ratio (eoy) x40.330.8 130.7%  
Price / Book Value ratio x13.04.0 328.4%  
Dividend payout %72.720.6 352.6%   
Avg Mkt Cap Rs m410,513232,120 176.9%   
No. of employees `000NANA-   
Total wages/salary Rs m5,63612,876 43.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m53,48761,642 86.8%  
Other income Rs m1,5431,518 101.7%   
Total revenues Rs m55,03063,160 87.1%   
Gross profit Rs m12,0559,033 133.5%  
Depreciation Rs m7002,616 26.8%   
Interest Rs m160482 33.2%   
Profit before tax Rs m12,7387,453 170.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,2442,534 128.0%   
Profit after tax Rs m9,4944,919 193.0%  
Gross profit margin %22.514.7 153.8%  
Effective tax rate %25.534.0 74.9%   
Net profit margin %17.88.0 222.4%  
BALANCE SHEET DATA
Current assets Rs m30,25151,893 58.3%   
Current liabilities Rs m12,06018,058 66.8%   
Net working cap to sales %34.054.9 62.0%  
Current ratio x2.52.9 87.3%  
Inventory Days Days8751 169.6%  
Debtors Days Days26 36.9%  
Net fixed assets Rs m15,13534,336 44.1%   
Share capital Rs m213254 83.8%   
"Free" reserves Rs m31,24858,167 53.7%   
Net worth Rs m31,46058,420 53.9%   
Long term debt Rs m06,518 0.0%   
Total assets Rs m45,38686,229 52.6%  
Interest coverage x80.716.5 489.9%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x1.20.7 164.9%   
Return on assets %21.36.3 339.6%  
Return on equity %30.28.4 358.4%  
Return on capital %41.012.2 335.5%  
Exports to sales %0.442.9 1.0%   
Imports to sales %10.813.3 81.2%   
Exports (fob) Rs m22126,434 0.8%   
Imports (cif) Rs m5,7658,178 70.5%   
Fx inflow Rs m31026,434 1.2%   
Fx outflow Rs m5,8188,178 71.1%   
Net fx Rs m-5,50818,257 -30.2%   
CASH FLOW
From Operations Rs m8,9348,058 110.9%  
From Investments Rs m-1,477-7,250 20.4%  
From Financial Activity Rs m-6,3875,072 -125.9%  
Net Cashflow Rs m1,0705,881 18.2%  

Share Holding

Indian Promoters % 0.0 46.3 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 8.9 44.8 19.9%  
FIIs % 0.2 10.3 1.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 53.7 46.6%  
Shareholders   72,252 82,809 87.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Abbott India vs IPCA Labs

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Abbott India vs IPCA Labs Share Price Performance

Period Abbott India IPCA Labs S&P BSE HEALTHCARE
1-Day -0.32% 3.49% 1.18%
1-Month -6.96% 4.42% -0.75%
1-Year 23.50% 56.71% 61.82%
3-Year CAGR 20.97% 9.51% 18.16%
5-Year CAGR 29.63% 20.92% 19.79%

* Compound Annual Growth Rate

Here are more details on the Abbott India share price and the IPCA Labs share price.

Moving on to shareholding structures...

The promoters of Abbott India hold a 75.0% stake in the company. In case of IPCA Labs the stake stands at 46.3%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Abbott India and the shareholding pattern of IPCA Labs.

Finally, a word on dividends...

In the most recent financial year, Abbott India paid a dividend of Rs 325.0 per share. This amounted to a Dividend Payout ratio of 72.7%.

IPCA Labs paid Rs 4.0, and its dividend payout ratio stood at 20.6%.

You may visit here to review the dividend history of Abbott India, and the dividend history of IPCA Labs.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.